Modernization Efforts Are Streamlining Regulatory Processes, FDA Report Finds

The seven-year effort to modernize FDA’s New Drugs Regulatory Program (NDRP) has paid off, with improvements in assessing drug approval applications, monitoring drug safety, operational efficiency and recruiting and retaining staff, according to a new CDER report.
Source: Drug Industry Daily